Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
Matinas BioPharmaJohnson & Johnson
Last price
$0.92$283.52
Currency
USD
USD
$1.2M$675B
-42.59
-$17.87$6.58
1.700.21
0$5.28
01.91%
Sector
HealthHealth
Employees
2138,200
Ticker
$MTNB$JNJ
Primary listing
AMEXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in $MTNB or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.